Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
353 hedge funds and large institutions have $1.02B invested in Avanos Medical in 2015 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 81 increasing their positions, 162 reducing their positions, and 92 closing their positions.
16% less funds holding
Funds holding: 419 → 353 (-66)
32% less capital invested
Capital invested by funds: $1.49B → $1.02B (-$476M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 162
66% less call options, than puts
Call options by funds: $2.22M | Put options by funds: $6.45M
68% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 92
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
+$108M |
| 2 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
+$14.1M |
| 3 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$10.9M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$8.7M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
RR Partners
New York
|
-$44.3M |
| 2 |
GAM
Gotham Asset Management
New York
|
-$24M |
| 3 |
FMA
Fiduciary Management Associates
Chicago,
Illinois
|
-$20.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18.4M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$15.3M |
AVNS Hedge Fund Activity: Q3 2015 in Review
353 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2015, worth a combined $1.02B — down 32% from $1.49B a quarter earlier.
Sellers outnumbered buyers: 92 funds closed out of AVNS and 29 opened new positions — a net loss of 63 holders — while 162 trimmed existing stakes and 81 added.
The largest buyer was Shapiro Capital Management, opening a new position worth an estimated $108M. The largest seller was RR Partners, cutting an estimated $44.3M.
- 353 institutional investors held Avanos Medical (AVNS) as of Q3 2015, down from 419 in Q2 2015.
- Funds reported $1.02B of Avanos Medical stock for Q3 2015, down 32% quarter-over-quarter.
- 29 funds opened new Avanos Medical positions in Q3 2015 and 92 closed out, a net change of -63 holders.
- The largest Avanos Medical buyer in Q3 2015 was Shapiro Capital Management, an estimated $108M added.
- The largest Avanos Medical seller in Q3 2015 was RR Partners, an estimated $44.3M sold.
Based on aggregated 13F filings for Q3 2015.